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Abstract 
               Introduction. Antimicrobial resistance is a growing international 
problem resulting from the enzyme β-lactamase production by bacteria, to 
degrade antibiotics, especially β-lactam antibiotics. In Brong Ahafo Regional 
Hospital, Sunyani, these antibiotics are heavily depended upon for the 
treatment of serious infections, but unfortunately high proportions of 
bacterial isolates in the hospital, have been found to be resistant to the 
commonly prescribed antibiotics. This study aims to determine the 
prevalence of ESBL-producing E. coli so as to determine if ESBL are 
responsible for the high antimicrobial resistance seen at the Brong-Ahafo 
Regional Hospital, Sunyani. 
Methods. The study was a cross sectional study, involving 51 E. coli isolates 
from urine samples of both in- and out-patients between January and 
December, 2014. Antimicrobial susceptibility profiles of the isolates were 
determined by the Kirby Bauer disc diffusion method against 12 antibiotics. 
The isolates were screened for ESBL production, and then confirmed by the 
combined disc method. The isolates were tested for the presence of ESBL 
blaCTX-M and blaTEM by conventional PCR.  
Results. Non-repeat 1,302 midstream urine samples were cultured from 
which 200 different pathogens were isolated. Of the 200 isolates 51 were E. 
coli.  Isolates obtained from Community isolates were 16(37.2) and isolates 
from in-patients were 27(62.8). Resistant strains were detected to all the 12 
antimicrobials tested. Low proportions were sensitive to cephalosporins 
(cefotaxime and ceftazidime), both recording 8/51(15.7%), and quinolones 
(nalidixic acid and ciprofloxacin), 7/51(13.7%) and 8/51(15.7%) 
respectively. The isolates had varied susceptibility to aminoglycosides, with 
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low sensitivity of 1/32(2.0%) to gentamicin, but a high proportion of 
47/51(92.2%) was sensitive to amikacin. High proportion of the isolates 
[43/51(84.3%)] were ESBL phenotype, and was found to be significantly 
associated (p<0.001) with antimicrobial resistance among the isolates. The 
most prevalent ESBL genotype was BlaTEM with 26 (66.7%) and blaCTX-M 
28(71.8%), but 9(23.1%) ESBL phenotypes tested negative for both blaTEM 
and blaCTX-M genes. 22 (56.4%) of the isolates had both blaTEM and blaCTX-M 
genes. 
Conclusion. High proportions of E. coli isolates from urine in Sunyani 
produce ESBLs. Both blaTEM and blaCTX-M were prevalent and linked to the 
high levels of drug resistance found in the locality. Increased antibiotic 
stewardship and stringent infection control measures along with the testing 
for ESBL must be instituted in the hospital. 
 
Keywords: Extended-Spectrum Beta-lactamase, UTI, antibiotic resistance, 
CTX-M and TEM. 
 
Introduction 
              Overuse of antibiotics is regarded as one of the many reasons for the 
rising trend of resistance observed among different pathogens, (Gonçalves et 
al., 2016) all over the world and grave concern has been expressed about the 
increase in the numbers of organisms that are multi-drug resistant and the 
difficulty encountered in their treatment (Hima-Lerible et al., 2003; 
Howladar and Gandhi, 2016). In the choice of antimicrobial for treatment, β-
lactam antimicrobials are preferred because they are highly effective against 
several bacterial pathogens, with minimal side effects and reduced toxicity, 
(Chiriac et al., 2016) as a result, β-lactam antibiotics are frequently 
prescribed and oftentimes indiscriminately (Newman et al., 2006; Bassetti et 
al., 2016). As a result, resistance to β-lactam antibiotics is substantially on 
the ascendancy becoming a frequent problem encountered in medical 
practice (Fisher et al., 2005). As the introduction of third generation 
cephalosporins into any community comes along with it the emergence of 
ESBLs, (Pitout et al., 2004; Paterson and Bonomo, 2005; Perez et al., 2007). 
β-lactamase production effectively terminates β-lactam activity and serve as 
the predominant resistance mechanism among Gram-negative bacteria 
including E coli (Bonnet, 2004; Hertz et al., 2016). ESBLs have extended 
activity against alternative antibiotic groups like the aminoglycosides and the 
fluoroquinolones, so ESBL-producing organisms become resistance to them 
((Ramazanzadeh, 2010).  
               In Ghana these antibiotics are the mainstay for the treatment of 
many infections including UTI, but routine screening of isolates for ESBLs 
is not done, because of the additional cost it constitutes to the patient, lack of 
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testing facilities to the technicians, and the general lack of interest among 
clinicians (Newman et al., 2006). Heavy dependence of β-lactam antibiotics 
leads to the development of β- lactamases and resistance as evident in high 
resistance proportions reported from teaching Hospitals in Ghana mainly 
Korle Bu Teaching Hospital(KBTH) (Opintan and Newman, 2007; Obeng-
Nkrumah et al., 2013 ) and Komfo Anokye Teaching Hospital (KATH) 
(Feglo et al., 2013). Studies on ESBLs have not been conducted from 
secondary referral hospitals such as the Brong Ahafo Regional Hospital, in 
Sunyani. This study therefore is to determine the prevalence of ESBL 
phenotype and genotypes among E. coli strains obtained from UTI patients at 
Sunyani and to determine their antimicrobial susceptibility patterns.  
 
METHODS 
Study design and setting 
This was a cross-sectional study conducted at the Brong Ahafo 
Regional Hospital, which is a 300-bed and secondary referral hospital in the 
Brong Ahafo Region, with population of about two million inhabitants. The 
Region has 19 districts with Sunyani as the Regional capital.  
Urine samples for the study were obtained from patients referred to the 
Microbiology Laboratory of the hospital for UTI investigations. Patients who 
gave their informed consent had their samples included in the study. Ethical 
clearance was obtained from the Institutional Ethics Committee of the 
Brong- Ahafo Regional Hospital, Sunyani.   
 
Bacterial isolation  
Early morning, mid-stream urine samples were received from 
patients at the Microbiology laboratory and plated on cysteine lactose 
electrolyte deficient (CLED) agar using a 1/400µm calibrated loop and pure 
colonies of ≥25 growing on CLED agar after overnight incubation at 37°C 
were considered significant for diagnosis of urinary tract infection. This is 
equivalent to growth of 10⁵ colony forming units/ml of one organism type 
and was considered significant bacteriuria. Where there were mixed growth 
of different organisms it was considered contamination and then rejected.  
The growths were identified by their colonial growth morphology on 
CLED medium. Lactose fermenting colonies, suspected to be E. coli were 
tested further using Gram stain (Gram negative rods), positive in the motility 
test and then indole and methyl red positivity, citrate negative and Voges-
Proskauer negative tests.  
 
Antibiotic susceptibility testing 
Antibiotic sensitivity of the isolates was determined by the modified 
Kirby-Bauer method according the CLSI recommended guidelines (20th Inf. 
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Suppl. M100-S20). Each set of tests was controlled using susceptible E. coli 
control strain (ATCC 25922). Antimicrobials and their concentrations tested 
included: Ampicillin/Sulbactam 20ug, amikacin 30ug, cefotaxime 30ug, 
ceftazidime 30ug, chloramphenicol 30ug, ciprofloxacin 5ug, gentamicin 
10ug, ofloxacin 5ug, nalidixic acid 10ug, tetracycline 30ug, Levofloxacin 
5ug, and ceftizoxime 30ug.  
 
ESBL Screening and confirmation 
In the routine susceptibility testing strains with reduced zone 
diameters of ˂27mm and ˂22mm respectively to cefotaxime and or 
ceftazidime were suspected of producing ESBLs according to CLSI 
guidelines (CLSI, 2011). All suspect isolates in the screening test were 
confirmed using the cefpodoxime discs alone and combined discs of 
cefpodoxime and clavulanic acid (30μg+10μg) (Oxoid GmbH, Wesel, 
Germany). Isolates that produced increased zones of ≥5mm between 
cefpodoxime disc alone and the combined disc is considered an ESBL.  
Escherichia coli ATCC 25922 was used as ESBL negative control and 
Klebsiella pneumoniae ATCC 700603 was used as ESBL positive control. 
 
Molecular Characterization of ESBLs 
All confirmed ESBL phenotypes were tested for BlaTEM and blaCTX-M 
by PCR according previously described techniques (Monstein et al., 2007) 
and (Mulvey et al., 2003) Mulvey et al., 2004).  
Table 1. Primers for amplification of blaTEM and blaCTX-M 
Gene  Primer  sequence (5”-3”) siz
e 
Source 
 
BlaTEM    
TEM-F    ATGTGGCAGYACCAGTAARGTKTGGC  
593 
Monstein & 
LE, (2007) TEM-R      TGGGTRAARTARGSACCAGAAYCAGCG 
 
Bla CTX-M    
CTX-M-
U1        
ATGTGCAGYACCAGTAARGTKATGGC  
593 
Mulvey et al. 
(2003) 
CTX-M-
U2        
TGGGTRAARTARGTSACCAGAAYCAGC
GG 
Source: Bla CTX-M (Mulvey et al.,2003), and Bla TEM( Monstein & LE, 2007) Key for 
standard Mixed base symbols: R-A,G; Y-C,T; M-A,C; K-G,T; S-C,G; W-A,T; H-A,C,T; B-
C,G,T; V-A,C,G; D-A,G,T(Integrated DNA Technologies, Inc , USA) 
 
Data Processing and Analysis  
Continuous data were expressed as mean ±SD and categorical data 
expressed as proportion. Resistance proportions were compared using chi-
square tests. In all cases a p-value <0.05 was considered significant. The data 
were analyzed using Stata/IC 10.0 for windows (StataCorp LP, USA, 
http://www.stata.com).  
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RESULTS 
Antibiotic susceptibility pattern of E. coli 
Non-repeat midstream urine samples numbering 1,302 were cultured. 
Significant bacteriuria was detected and 200 different pathogens were 
isolated. Of the 200 isolates 51 were E. coli.  E. coli isolates obtained from 
community isolates were 16(37.2) and 27(62.8) were obtained from in-
patients. All the 51 E. coli isolates were tested against 12 different antibiotics 
namely Ampicillin/Sulbactam, nalidixic acid, cefotaxime, ceftazidime, 
chloramphinicol ciprofloxacin, ceftizoxime, tetracycline, ofloxacin, 
gentamicin, amikacin and levofloxacin, using the Disk-diffusion method.  
High proportions of the E. coli isolates were resistant to the various 
antimicrobial agents tested. The highest resistant proportions were found 
against tetracycline and ampicillin where they recorded (50/51 (98.0%) and 
(38/51 (74.5%) respectively. Varied resistant proportions were detected to 
the quinolones with 43/51(84.3%) to nalidixic acid and ofloxacin recorded 
36/51(70.6%), levofloxacin 27/51(52.9%) and ciprofloxacin 42/51(82.4%). 
Resistant proportions were detected against aminoglycosides and 
cephalosporins tested and the details are presented in table 2. 
Table 2. Antibiotic susceptibility pattern of E. coli isolated from urine at Sunyani. 
E. coli (n=51) AS NX CTX CAZ CH CP 
Sensitive 5(9.8%) 7(13.7%) 8(15.7%) 8(15.7%) 16(31.4%) 8(15.7%) 
       
Resistant  38(74.5%) 43(84.3%) 42(82.4%) 42(82.4%) 34(66.7%) 42(82.4%) 
       
Intermediate  8 (15.7%) 1 (2.0%) 1 (2.0%) 1 (2.0%) 1 (2.0%) 1 (2.0%) 
Total  51 51 51 51 51 51 
 
E. coli ( n=51)                   CL TE OF GM AK LE 
Sensitive                             31(60.8%) - 11(21.6%) 1(2.0%) 47(92.2%) 11(21.6%) 
      
Resistant                              12(23.5%) 50(98.0%) 36(70.6%) 30(58.8%) 2 (3.92%) 27(52.9%) 
      
Intermediate                         8 (15.7%) 1 (2.0%) 4 (7.8%) 1 (2.0%) 2 (3.9%) 13(25.5%) 
Total                                   51 51 51 32 51      51 
AS: Ampicillin/Sulbactam; NX: Nalidixic acid; CTX: Cefotaxime; CAZ: Ceftazidime; CL: 
Ceftriaxone; CH: Chloramphenicol; CP: Ciprofloxacin; TE: Tetracycline; OF: Ofloxacin; 
GM: Gentamicin; AK: Amikacin; LE: Levofloxacin. 
 
Prevalence of ESBL in urinary E. coli isolated from Sunyani 
Aminoglycoside resistance was also significantly associated with 
ESBL expression (p<0.0006). Twenty-seven strains (90.0%) were resistant 
to at least 1 of the 2 tested aminoglycosides with most frequently observed 
resistance against gentamicin 27(90.0%), while about 15(35%) were resistant 
to quinolones. Of the 51 E. coli isolates, 43 tested positive and 8 tested 
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negative for ESBL production. There was no significant association between 
ESBL production, gender and age (p<0.42) and (p<0.18) respectively (Table 
3).  
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Fig 1 Prevalence of EBL producing E. coli isolated from Sunyani 
Table 3. Association of Gender and Age with ESBL production in E. coli 
 
Total                    ESBL 
 
 
n=51 Positive n=43 Negative n=8 p-value 
Gender  
   Male 18 14 (32.6%) 4 (50.0%) 0.4297 
Female 33 29 (67.4%) 4 (50.0%) - 
Age group (years)     
Under five years 9 8(18.6%) 1 (12.5%) 0.1828 
Adults 42 35(81.4%) 7 (75.0%) - 
 
Values are presented as frequency (percentage). Difference between proportions was tested 
using Chi-square. p<0.05 was considered statistically significant. 
 
There was significant association between ESBL production and 
multi-drug resistance. Antimicrobial resistance was significantly associated 
with ESBL production (p<0.0001) (Table 4). 
Table 4 Comparison between antimicrobial drug resistance and ESBL production in E. coli 
 ESBL isolates 
N=43 
Non-ESBL              
isolates  
N=8 
               Total (N=51) 
                               %  
Resistance             
      % 
Resistance                
 P-values 
Cefotaxime      42/42(100.0)                     0/42(0.0)  < 0.01 
Ceftazidime   42/42(100.0)                   0/42(0.0)  < 0.01 
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Continuous data were presented as mean ± Sd and categorical data presented as 
proportion. Categorical data were compared to each other using Chi-square analysis. 0.05 
 
Molecular Characterization of ESBLs  
The two ESBL genes namely BlaTEM and BlaCTX-M tested for were 
detected among the 43 E. coli ESBL phenotypes. BlaTEM was detected in 26 
(66.7%). BlaCTX-M was detected in 28/43(65.1%) of the isolates. Twenty-two 
being 51.1% of the isolates were positive for both Bla CTX-M and BlaTEM 
genes. Phenotypically 9(20.9%) of isolates tested positive for ESBL but were 
negative for both BlaCTX-M and BlaTEM. Pictures of agarose gel separation of 
amplicons for BlaTEM and BlaCTX-M are shown in Figures 2 and 3. 
 
Isolates 087, 3212 and 2347 showed non- specific bands (presence of two genes) of 
593/200 while 876, 947, 2183, 2908, 4173 and 314 are negative for blaTEM +c depicts 
PCR product of E. coli  positive control and –c depicts PCR product of a negative control. 
L is the molecular weight standard 100bp (Thermo Scientific). Band size 593bps 
 
Fig 2. PCR amplicons on 2% agarose gel for BlaTEM genes of E. coli 
Ceftizoxime    9/12(75.0)                    3/12(25.0)  < 0.01 
Ciprofloxacin    36/42(85.7)         6/42(14.3)    0.84 
Levofloxacin    24/27(88.9)         3/27(11.1)   < 0.01 
Ofloxacin    32/36(88.9)                           4/36(11.1)   < 0.01 
Nalidixic acid    37/43(86.0)         6/43(14.0)    0.87 
Amikacin     2/2(100)                       0/2(0.0)  < 0.01 
Gentamicin     27/30(90.0)                      3/30(10.0)  < 0.01 
Ampicillin-
sulbactam 
    33/38(86.8)           5/38(15.2)  < 0.01 
Tetracycline      42/50(82.4)                     8/50(16.0)  < 0.01 
ESBL band (593bp) 
Non-specific 
band (200bp) 
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Isolates 3119**negative for bla CTX-M, +c and –c are positive and negative controls, L is 
ladder standard 100bp 
Fig 3. PCR amplicons on 2% agarose gel for bla CTX-M genes 
 
DISCUSSIONS  
 Several studies have demonstrated the presence of β-lactamases in 
Ghana, but most of these studies were conducted in tertiary referral 
institutions. Results similar to those obtained in tertiary referral hospitals 
were expected in Sunyani Hospital, because it is a secondary referral hospital 
and specialist services exist in this institutions too, just like other regional 
hospitals in Ghana. Patients are referred from many districts within the 
region and beyond to seek health care at the regional hospitals. It is cases 
beyond the competence of the regional hospitals that are referred to the 
tertiary levels in Kumasi and Accra. This problem of ESBL has not caught 
the attention of the health authorities and are missing in many medical 
reports from the health institutions. ESBLs are not just nosocomial infections 
in big hospitals in Ghana, but are spreading into the communities as well 
(Feglo et al., 2013). In this present study 43/51(84%) of the urinary E. coli 
isolates produced ESBL and 16(37.2%) were community isolates, an 
observation, which confirms findings in other studies that ESBL-producing 
Enterobacteria  are detectable in both community and hospitalized patients 
with varying prevalence levels as 63% was reported from Mali (Tande et al., 
2009), 43% in Ghana (Feglo et al., 2013), 40% in Niger (Woerther et al., 
2011) and 26% in Kenya (Kariuki et al., 2007) and 28.66% in  Bangladesh 
(Islam et al., 2017). It was estimated that ESBL prevalence of 80% in a 
hospital setting will lead to as much as 80% of treatments failures and 35% 
Bla CTX-M bands 
(593pbs) 
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mortality (Perez et al., 2007). The detection of more than 80% ESBL 
prevalence in Sunyani is of concern as deaths might have arisen from 
treatment failures as a result of ESBL problem in the Sunyani health facility. 
There are no ESBL records and ESBL treatment failures are not and cannot 
be accounted for because the hospital authorities are unaware of it and β-
lactam antibiotics are still prescribed. Even if hospital ESBL spread is 
controlled, the community ESBL auxotrough spread will persist and will 
replace normal antibiotic susceptible wild type in the community.   
Alternative antibiotic groups like the aminoglycosides and the 
fluoroquinolones, have also been affected by the ESBL menace because the 
enzymes have extended activity to non-beta lactam antibiotics too 
(Ramazanzadeh, 2010). As demonstrated in the present study, appreciable 
proportion of E. coli resistance was recorded against the quinolones, with 
resistance proportion to nalidixic acid being 84.3%, ofloxacin (70.6%), 
Levofloxacin (52.9%) and ciprofloxacin (82.4%).  
 ESBL carriage was observed to be significantly associated with 
antimicrobial resistance in E. coli isolates tested from Sunyani (p< 0.01), as 
was also observed in India (Jain et al., 2003) Bangladesh (Asna et al., 2017). 
Studies indicate that patients who have ESBL infection seem to have poorer 
prognosis than  patients infected with non ESBL bacteria (Paterson and 
Bonomo, 2005), and the reason may be due to treatment failures .  This is a 
serious issue given that immunity at extremes of life is relatively weak, a 
situation which prescribers must know of and must show optimum care for in 
the choice of antibiotics meant for patients less than 5years and above 60 
years.  
 There was increased resistance of E. coli to most of the 
antimicrobials tested, with the exception of amikacin to which resistant 
proportion was low (3.9%). Though 20.26% of community urinary isolates in 
Morocco were found to be multidrug resistant (Natoubi et al., 2017), 
elsewhere in China and India, amikacin and nitrofurantoin were reported to 
be effective drugs for the treatment for UTIs (Shao et al., (2004) and 
Mandira Mukherjee et al., (2013) respectively. In our study and in Nigeria 
high proportions of urinary isolates were resistant with all E. coli isolates 
(100%) being resistant to augmentin, gentamycin, streptomycin, tetracyclin 
and chloramphenicol, and 90.90% resistant to ofloxacin, sparfloxacin and 
amoxicillin (Elikwu et al., 2017). High resistant proportions seen in this 
current study is attributable to many factors. Firstly, many hospitals in Ghana 
do not have the competence and the facility to do bacterial culture, isolation 
and antimicrobial sensitivity testing, so physicians prescribe without 
laboratory support. The second factor is the indiscriminate use the drugs, 
because they are relatively cheap and easily accessible by the patient.  The 
drugs can be purchased off the counter due to lack of enforcement of 
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regulations, and also because some of these antibiotics are taken orally, so 
they are easy to administer and misuse (Newman et al., 2006). Another link 
to antibiotic resistance is the increased use of antibiotics in animal husbandry 
coupled with the production and sale of substandard and fake drugs (Tajick, 
2006; Shakoor et al., 1977). In the case of substandard drugs physicians 
prescribe adequate doses, but do not achieve optimal clinical response in-
vivo leading to the creation of resistant strains.  
In this study, BlaTEM was detected in 26 (66.7%) of the ESBL E. coli strains 
and bla CTX-M tested was detected in 28 (71.8%) of the isolates. These results 
are similar to other results obtained in studies in tertiary institutions in Ghana 
where higher BlaTEM were reported than the BlaCTX-M among E. coli strains 
(Obeng-Nkrumah et al., 2013 ; Labi et al., 2016). 
 Studies in Europe and America reported more prevalence of SHV 
and CTX-M-β-lactamase organisms than the TEM (Bonnet, 2004; Naseer 
and Sundsfjord, 2011), but most studies in Ghana report the TEM ESBL as 
the most common, just as it is found in the current study in Sunyani. Though 
tested phenotypically to be ESBLs about 20.9 % of the ESBL-producing 
isolates in this study were negative for the both BlaCTX-M and BlaTEM an 
indication that other ESBLs types could be present. 
The increased diversity and complexity of β-lactam resistance in gram-
negative organisms, have necessitated the call for stringent infection control 
and antimicrobial stewardship. Also increased establishment of institutional 
testing facilities, training of personnel and continuous monitoring of drug 
resistance Sunyani Hospital is suggested.  Testing for other BlaGENES such as 
for SHV, AmpC, OXA, KPC and IMP and VIM in E coli and other members 
of the Enterobacteriaceae is advocated.  
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